Trending Videos
Shorts
0:33
Nemolizumab & Itch: Why Pruritus Needs to Be Addressed
2 days ago
by
Sarina B Elmariah, MD, PhD
0:34
New FDA Approvals and Innovations in Skin Cancer Treatment
3 days ago
by
Todd Schlesinger, MD
0:35
Razor Bumps in Patients with Skin of Color: What to Know
5 days ago
by
Yoseph Dalia, MD, MBA(+1 more)
0:46
Which Populations Experience More Severe ‘Razor Bumps’?
7 days ago
by
Prince Adotama, MD(+1 more)
1:18
The Hidden Signs of Alpha-Gal Syndrome You Might Be Missing
9 days ago
by
Chirag Patel, MD
0:43
Defining Success in Ulcerative Colitis Treatment
10 days ago
by
Stefan Schreiber, MD
0:35
Why Proposed Medicare Cuts Threaten Skin Cancer Patients
10 days ago
by
Shannon C. Trotter, DO
1:09
The Hidden Danger of SGLT2 Inhibitors for Type 1s
10 days ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)
1:07
How Anaphylaxis Management Changed Over the Last 5 Years
11 days ago
by
Manish Ramesh, MD, PhD
0:43
The Link Between IBS Medication and Doctor Visits
11 days ago
by
Kyle Staller, MD, MPH
Advertisement
Advertisement
Trending on HCPLive
1
eGFR Underestimates CKD in Patients with Cancer, Study Finds
2
Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD
3
Tegoprubart Improves Quality of Life vs Tacrolimus After Kidney Transplant
4
GLP-1s Tied to Weight Loss in Peritoneal Dialysis, With Steven Brunelli, MD
5